Compare AbbVie Inc (ABBV) vs Howmet Aerospace Inc (HWM) Price & Performance

AbbVie (ABBV) trades at $249.9, up 0.8% on the day, with strong analyst support (29 Buy, 1 Sell) and a $278.69 consensus price target. Recent quarterly earnings have consistently beaten estimates, driven by robust immunology drug sales. The stock shows a bullish technical trend, supported by moving averages, and the company maintains solid cash flow and dividend payments.

Outlook is positive with revenue growth and pipeline advancements, though high P/E and debt levels pose risks. The stock offers a compelling buy case for growth and income investors, balanced by execution and patent expiry challenges ahead.

Howmet Aerospace (HWM) trades at $283.94, up 0.08% with strong bullish momentum following consecutive earnings beats. The stock shows robust fundamentals with Q2 2026 EPS of $1.33 beating estimates by 7.3%, driven by 24% revenue growth in aerospace and defense markets. Technical indicators signal bullish momentum with the current price above key support levels. The company raised full-year 2026 guidance, reflecting confidence in continued demand across commercial aerospace and gas turbine segments.

Outlook remains positive with 84% analyst buy ratings and $334.63 consensus price target suggesting 18% upside. Key risks include execution of capacity expansion plans and potential supply chain constraints. The combination of strong earnings momentum, raised guidance, and institutional support positions HWM for continued growth, though investors should monitor Q3 2026 results due for confirmation of guidance sustainability.